TY - JOUR T1 - Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the ‘breakthrough’ JF - Evidence Based Medicine JO - Evid Based Med SP - 83 LP - 86 DO - 10.1136/ebmed-2015-110325 VL - 21 IS - 3 AU - Martin Mayer Y1 - 2016/06/01 UR - http://ebm.bmj.com/content/21/3/83.abstract N2 - ER -